STOCK TITAN

Elanco (ELAN) officer Rajeev Modi receives deferred stock unit grant

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Modi Rajeev A. reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health Inc reported that officer Rajeev A. Modi received a grant of deferred stock units under a company plan. The award covers 61.9258 deferred stock units tied to Elanco common stock at a reference price of $23.85 per unit.

Each deferred stock unit represents the right to receive one share of Elanco common stock or the cash equivalent, according to the company’s Executive Deferral and Stock Match Plan. After this grant, Modi holds a total of 9,401.9142 deferred stock units directly.

Positive

  • None.

Negative

  • None.

Insights

Routine deferred stock unit grant tied to compensation plan.

The transaction is an acquisition of 61.9258 deferred stock units by officer Rajeev A. Modi as a grant or award, not an open-market trade. These units reference Elanco common stock at a stated value of $23.85 per unit.

Each deferred stock unit represents a right to receive either one share of common stock or cash, settling after employment ends or in a designated future year under the Executive Deferral and Stock Match Plan. This makes the event largely administrative, reflecting normal executive compensation rather than a directional view on the stock.

Following the grant, total direct deferred stock unit holdings are 9,401.9142 units. There are no remaining derivative positions listed in this filing beyond these units, and no sales or option exercises are reported, underscoring the routine, non-market nature of the transaction.

Insider Modi Rajeev A.
Role SEE REMARKS
Type Security Shares Price Value
Grant/Award Deferred Stock Units 61.9258 $23.85 $1K
Holdings After Transaction: Deferred Stock Units — 9,401.9142 shares (Direct)
Footnotes (2)
  1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
  2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Deferred stock units granted 61.9258 units Grant/award acquisition on May 29, 2026
Transaction price per unit $23.85 Reference price for deferred stock unit grant
Deferred stock units after transaction 9,401.9142 units Total direct holdings following grant
Underlying common stock ratio 1 share per unit Each unit represents one share or cash equivalent
Conversion or exercise price $0.00 Deferred stock units reported with zero exercise price
Deferred Stock Units financial
"Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent."
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
Executive Deferral and Stock Match Plan financial
"Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan."
Common Stock financial
"Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Elanco (ELAN) report for Rajeev A. Modi?

Elanco reported that officer Rajeev A. Modi received a grant of 61.9258 deferred stock units. These units are part of his equity-based compensation and are linked to Elanco common stock, rather than being bought or sold on the open market.

How many deferred stock units does Rajeev A. Modi hold after this Elanco (ELAN) Form 4?

After this Form 4 transaction, Rajeev A. Modi directly holds 9,401.9142 deferred stock units. This total includes the new 61.9258-unit grant reported in the filing and represents his accumulated deferred equity-based compensation under the company’s plan.

Is the Elanco (ELAN) Form 4 transaction a market buy or sell of shares?

No, the Form 4 transaction is not a market buy or sell. It reflects a grant of 61.9258 deferred stock units as compensation, coded as an acquisition (A), rather than an open-market purchase or sale of Elanco common stock by the officer.

What does each deferred stock unit represent in the Elanco (ELAN) filing?

Each deferred stock unit represents the right to receive one share of Elanco common stock or the cash equivalent. Settlement occurs after employment ends or in a specified future year under the Executive Deferral and Stock Match Plan described in the Form 4 footnotes.

When do the Elanco (ELAN) deferred stock units for Rajeev A. Modi settle?

The deferred stock units settle in cash or Elanco common shares following termination of employment or during a specified future year. The timing follows the terms of Elanco’s Executive Deferral and Stock Match Plan referenced in the Form 4 footnotes.

What is the reference price for the Elanco (ELAN) deferred stock unit grant?

The reported transaction lists a price of $23.85 per deferred stock unit. This figure is used in the Form 4 as the transaction price per unit for the 61.9258 deferred stock units granted to officer Rajeev A. Modi under the company’s compensation plan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Modi Rajeev A.

(Last)(First)(Middle)
C/O ELANCO ANIMAL HEALTH INCORPORATED
450 ELANCO CIRCLE

(Street)
INDIANAPOLIS INDIANA 46221

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SEE REMARKS
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Deferred Stock Units(1)05/29/2026A61.9258 (2) (2)Common Stock61.9258$23.859,401.9142D
Explanation of Responses:
1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Remarks:
Executive Vice President U.S. Pet Health and Global Digital Transformation
/s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi06/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)